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Abstract
This is the first extensive interdisciplinary research in Romania focusing on psychosocial aspects of hospitalized adult cancer
patients that includes data from a multi-center questionnaire screening and multivariate analysis. According to the tumor
location, our mixed sample includes 420 adult oncology patients, 342 with malignant and 78 with benign tumors. Results
show that in our sample 16.9% of cancer patients are not aware of their oncologic diagnosis, 47.5% are clinically depressed,
46.7% experience anxiety disorders and 28.1% report low quality of life. Based on our results, we propose the routine use of 
self-administered questionnaires for better identification of psychosocial needs.
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1. Introduction
Although cancer morbidity and mortality are not considered incidents of civilization (Lapis, 2001), still in
Europe each year around 3.2 million new cancer cases are diagnosed and 1.7 million deaths are recorded due to
neoplastic diseases (Ferlay et al., 2007). According to the WHO, a 50% growth in cancer incidence is expected
by 2020, which is 16 million new cancer patients and 10.3 million cancer deaths worldwide over the next decade
(WHO-IARC, 2008; WHO, 2008a, 2008b).
Cancer development, pathology and prognosis have multifactor origins and aspects. Based on a psycho-
oncologic approach and relevant literature, we can assume that psychosocial factors have a particular role in
cancer diseases, since they contribute to the continuation or exacerbation of this chronic disease (
2008).
Earlier studies concluded that the role of disease-related psychosocial variables and effects in the cancer
process and progression is more coinciding, convincing and reliable than the impact of psychosocial factors on
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cancer diagnosis and development. However, based on recent empirical data, there are still numerous 
unexplained or unanswered questions in the relation, interconnection between the cancer process, progression 
and various psychosocial aspects (Garssen, 2004). 
Assessment of distress and quality of life variables in cancer patients has equal importance to revealing the 
bio-psycho-social etiology and cancer risk, since it has been evidenced that quality of life is a significant 
prognostic factor of cancer progression and mortality, comparable with medical and treatment-related factors. For 
example, in the past 20 years, the high proportion of unmet, untreated psycho-social needs in cancer patients has 
not changed, except for significant progress in pain relief, alleviation of adverse reactions to oncologic treatments 
and the significant development of psycho-oncology, meaning increased awareness of the fact that psychosocial 
factors influence physiological processes which stimulate carcinogenic growth and invasion (Barg et al., 2007). 
We started our research on psychosocial aspects of cancer by applying the bio-psycho-social research 
framework. In our clinical study we put emphasis on psychosocial aspects (e.g. diagnosis, depression, and quality 
of life), because objective characteristics, such as particularities of tumors, give uncertain indications for 
understanding how cancer patients cope with the chronic condition. 
The basic aim of our research is to explore and examine cancer-related distress and quality of life aspects, with 
specifics of cancer diagnosis disclosure in Romania. 
2. Objectives 
Our study investigated actual bio-psycho-social and spiritual states of hospitalized adult cancer patients in 
Transylvania, Romania, and their well-being (quality of life). The relevancy of our clinical research should be 
addressed and evaluated starting from the fact that in Romania there are no relevant or scientific data about 
cancer diagnosis non-disclosure, cancer distress (depression and anxiety) and cancer-related quality of life, based 
on multivariate statistical analyses. Also, we have no knowledge of psycho-oncologic studies, such as surveys 
carried out on large hospitalized samples in Romania. 
2.1. Key objectives 
 to analyze demographic, medical and psychosocial factors that may explain the non-disclosure of cancer 
diagnosis to patients; 
 to measure prevalence of psychosocial distress, especially depression and anxiety symptoms, mental health 
disorders and low-level quality of life; 
 to identify explanatory variables and effect-mechanisms, mode of action related to depressive symptomatology 
and quality of life in cancer patients; 
 to compare cancer disclosure and non-disclosure, clinical and non-clinical depression and also low and high 
quality of life in cancer patients in relation to demographic, medical, lifestyle and psychosocial factors. 
3. Methods 
3.1. Study population 
According to the tumor location, our heterogenic, mixed sample includes 420 adult oncology patients, 342 
with malignant and 78 with benign tumors. Data collection was performed in four clinical settings, in the most 
comprehensive and largest oncologic institutions in the Transylvania region of Romania. The study was approved 
 Napoca, Romania. 
The sampling methods and other specific measurements are published in detail elsewhere ( , 2009b, 
2009c; Degi, 2008). 
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3.2. Measurement of psychosocial factors 
     Quality of life was measured by the Functional Assessment of Cancer Therapy General (FACT G 4.0) 
(Cella, 1997; DF;  Cella et al., 1993), a multi-dimensional questionnaire (Cronbach alpha=0.70). Presence and 
severity of depressive symptoms were measured using the nine-item short version of the Beck Depression 
Inventory (BDI) (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961; ) (Cronbach 
alpha=0.86). Spielberger's State Trait Anxiety Inventory (STAI T) (Spielberger, Gorsuch, & Lushene, 1970) 
 
Shortened Hopelessness Scale (Beck, Weissman, Lester, & Trexler, 1974) (Cronbach alpha=0.86). Shortened 
Vital Exhaustion Questionnaire (Appels, 1997; Appels & Mulder, 1988; M. S. Kopp, Falger, Appels, & 
Szedmak, 1998) was used to assess levels of fatigue, chronic stress (Cronbach alpha=0.81). Life events were 
measured by means of a 16 nd Coping Inventory/Life 
Events Rating Scale (Rahe & Tolles, 2002) (Cronbach alpha=0.55). Dissatisfaction with family support was 
measured by the Social and Emotional Loneliness Scale (SELSA) (Di'Tommaso & Spinner, 1993) (Cronbach 
alpha=0.85). Using the Multidimensional Health Locus of Control Scale (MHLCS) (Wallston, Wallston, & 
DeVellis, 1978), we evaluated external locus of control (Cronbach alpha=0.68). The Illness Intrusiveness Rating 
Scale (IIRS) (Devins, 1994) was used to assess the impact of illness on various domains of functioning 
(Cronbach alpha=0.89). Coping processes, thoughts and actions that patients use to cope with the stressful 
situation, were identified using the Shortened Ways of Coping Questionnaire (WAYS) (Folkman & Lazarus, 
1980; Lazarus, 1993) d 
Coping Inventory/Sense of Coherence Scale ( ) (Cronbach alpha=0.64). 
Self efficacy was measured by the Shortened Generalized Self Efficacy Scale (M.S. Kopp, Schwarzer, & 
Jerusalem, 1993; Schwarzer, 1993) (Cronbach alpha=0.74) and patterns of maladaptive thinking by Shortened 
Dysfunctional Attitude Scale (Weissman, 1979) (Cronbach alpha=0.64). Shortened Type D Scale (Denollet, 
1998) was used to measure social, behavior inhibition in cancer patients (Cronbach alpha=0.75).  
3.3. Statistical analysis 
The data were entered into SPSS 15.0 and AMOS 7.0. Chi-square tests have been conducted to compare 
categorical data. Least square means tests for continuous variables have been calculated (general linear model, 
with 95% confidence intervals). Furthermore, the following multivariate statistical analyses were carried out: 
partial correlation, analysis of covariance (ANOVA), hierarchical logistic regression (odd ratios - OR - with 95% 
confidence intervals), stepwise linear regression and path analysis.   
We conducted partial correlation to determine the relationship between continuous variables, direction and 
strength of the relationship, while controlling for other variables involved in our study. Analysis of covariance 
allowed inclusion of supplementary variables (covariates) into the general linear model, eliminating other effects, 
factors that might determine the dependent variable. Using binary logistic regression analysis, we identified 
relevant factors (independent variables), which significantly differentiate the two test groups (dependent 
variables) and we also predicted the odds, probability of cancer diagnosis non-disclosure, clinical depression and 
low quality of life. Linear regression analysis helped us understand how the typical value of the dependent 
variable changed when any one of the independent variables were varied, while other involved variables were 
held fixed. We used stepwise method, because it is recommended for exploratory work and it has the best 
predictive power. In addition to standard multivariate statistical analyses, path analysis was also performed. 
Our multivariate statistical analyses were fully adjusted, controlling for age, gender, place of residence, 
education, marital status, subjective economic status, religion, nationality, cancer diagnosis disclosure, reactions 
to cancer diagnosis, cancer type, site and stage, treatment conditions (surgery, chemotherapy and radiation 
therapy), and self-rated health. 
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4. Results 
Results show that in our sample 16.9% of cancer patients are not aware of their oncologic diagnosis, 47.5% 
are clinically depressed, 46.7% experience anxiety disorders and 28.1% report critically low quality of life. 
85.4% of those suffering from clinical depression and 90.7% of persons with low quality of life are patients with 
malignant cancer diseases. 75.9% of cancer patients who report low quality of life are also facing clinically 
relevant depression symptoms. Moreover, almost two thirds of cancer patients to whom cancer diagnosis was not 
disclosed are highly or severely depressed. 
4.1. Cancer diagnosis non-disclosure 
In our study sample, almost every fifth hospitalized cancer patient was not informed about his/her cancer 
diagnosis. Furthermore, our results are of considerable potential importance, because they clearly show that 
patients who are not informed about their cancer diagnosis are significantly more depressed, hopeless and with 
lower levels of problem focused coping compared to patients who are informed. Also, patients who were not told 
about their cancer diagnosis tended to be older, with a mandatory education or less and living in small 
communities.  
The odds of not being personally informed about cancer diagnosis was highly increased by malignant cancer 
diseases (OR=10.56), clinical, severe depression (OR=5.14) and lack of chemotherapy treatment (OR=4.65). 
4.2. Cancer distress 
Prevalence of clinical depression in our study sample is high. Almost half of hospitalized cancer patients 
involved in our study are clinically depressed most likely requiring treatment. Among clinically depressed cancer 
patients, the proportion of respondents over 65 years, with mandatory or less education, widowed and who were 
not informed about their cancer diagnosis, was significantly higher compared to patients without clinical 
depression. 
Increasing clinical depression was significantly associated with advanced disease stage; worsening state of 
health, lack of physical activity, cancer diagnosis non-disclosure and passive-negative reactions to cancer 
diagnosis. Also, our results show significant negative correlation between clinical depression and quality of life, 
and strong positive correlation between moderate-to-severe depression, hopelessness and anxiety. 
Our data demonstrate the broad negative impact of depressive symptoms requiring treatment on psychosocial 
functioning and well-being, quality of life, independent of demographic, medical and unhealthy lifestyle 
determinants. In clinically depressed cancer patients, we found significantly higher hopelessness, higher anxiety, 
higher vital exhaustion scores, more lack of social support, and higher levels of emotion-focused coping, 
behavior inhibition, and dysfunctional attitude, more prevalent external locus of control and significantly lower 
self-efficacy and sense of coherence. Furthermore, the differences of 8-10 and 2-3 points in average score (Cella, 
Hahn, & Dineen, 2002) revealed by our data in relation to quality of life and particularly physical and functional 
well-being are of clinically significant importance.  
The odds of clinical depression are fivefold higher for female cancer patients, more than fourfold higher for 
cancer patients with high levels of emotion-focused coping and hopelessness, threefold higher for cancer patients 
with low quality of life and high vital exhaustion, dysfunctional attitude and anxiety and almost twofold higher 
for cancer patients who experience high illness intrusiveness, social-behavior inhibition and low self-efficacy, 
sense of coherence and also who are negatively assessing their childhood. 
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4.3. Quality of life
We have found negative trend in quality of life to be significantly related to low education, widowhood, small-
town residence, absence of religious practice, malignant cancer, advanced disease stage, helpless-control lacking
reactions to cancer diagnosis, poor/very poor health status, physical inactivity, and severe depression. Positive
trend in quality of life was significantly associated with high education, married family status, regular religious
practice in church, benign tumor, initial stage of disease, hopeful reactions to cancer diagnosis - faith in God,
determination of healing and denial of disease, very good health, weekly/daily physical activity and the absence
of depression. Not only statistically, but also clinically significant differences in quality of life scores (average
score differences of 8-10 points) (Cella et al., 2002) were found related to education, practice of religion, health
status and depression. Also, depression, anxiety, vital exhaustion, hopelessness and illness intrusiveness were
significantly and negatively correlated with quality of life, while sense of coherence was positively correlated
with it.
Our empirical model based on path analysis showed that quality of life in patients with malignant tumors is
defined, on the one hand, by a negative pathway related to anxiety, vital exhaustion and illness intrusiveness and,
on the other hand, by a positive pathway involving happiness, self-efficacy, and sense of coherence / meaning of 
life. Results of path analysis are presented below (Figure 1).
Figure 1. Path analysis using AMOS
Dependent variable - quality of life of patients with cancer
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In addition, regression analyses carried out according to gender, tumor type, site and stage of disease revealed 
that anxiety and vital exhaustion are common explanatory, predictive factors of low, worsening quality of life in 
hospitalized cancer patients. 
Likelihood (odds) of low quality of life in cancer patients was significantly increased 4.82 fold by severe 
depression, 4.22 fold by malignant tumor, 3.60 fold by helpless control lacking reactions to cancer diagnosis, 
3.41 fold by small town residence, 3.39 fold by low levels of problem focused coping, 3.25 fold by vital 
exhaustion, and 2.29 fold by illness intrusiveness. 
5. Conclusions, new statements 
In our psycho-oncologic study, the investigated psychosocial variables were found to have independent effect 
on cancer diagnosis disclosure, cancer-related distress and well-being, quality of life, and to be significant 
prognostic factors for cancer diagnosis non-disclosure, clinical depression and low quality of life, even after 
having been adjusted according to all demographic, medical and lifestyle factors included in the analysis. 
This is the first extensive interdisciplinary research in Romania focusing on psychosocial aspects of 
hospitalized adult cancer patients that includes data from a multi-center questionnaire screening, survey and 
multivariate data analysis. Many of the results are of international interest.  
1. Based on questionnaire screening, we published new and also reference data on the prevalence of cancer 
diagnosis non-disclosure, cancer distress and low quality of life in the Transylvania region of Romania. 
2. We determined the mean scores for the hospitalized adult cancer patients on the psychiatric screening 
questionnaires (BDI and STAI-T) and on quality of life scale (FACT-G 4.0) used in the present study. 
3. In accordance with some recent international studies, we have demonstrated the relevant and widespread 
negative effects of cancer diagnosis non-disclosure, of clinical depression and of low quality of life on 
psychosocial functioning and vulnerability of hospitalized cancer patients. Our data, based on multivariate 
statistical analyses, demonstrate that their prevalence, on the one hand, significantly increases hopelessness, 
illness intrusiveness, anxiety, vital exhaustion, depression, emotion-focused coping, lack of family support, 
behavior inhibition and external locus of control and, on the other hand, decreases problem-focused coping, 
physical-, emotional-, social/familial- and functional well-being, sense of coherence and self-efficacy in cancer 
patients.  
4. We identified and summarized the demographic, medical and psychosocial characteristics of those groups of 
cancer patients that have significantly increased odds for cancer diagnosis non-disclosure, cancer distress and 
worsening of quality of life. Here, one of the most important findings is that cancer diagnosis non-disclosure, 
clinically significant depression and seriously decreased quality of life are more prevalent among persons with 
malignant tumors and among older, undereducated, widowed and socio-economically deprived cancer patients. 
Based on our psycho-oncologic research, we propose the routine use of self-administered questionnaires in 
oncology settings and services for better identification of psychosocial problems, needs. 
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